Related Topics News -

     
 Title only   |   Print 
     
《業績》巨子生物中期純利11.82億人民幣增20.2% 不派息

2025-08-27T  
《大行》匯豐研究:「可復美」產品負面新聞令巨子生物增長可見度下降 目標價降至74.6元

2025-07-23T  
《大行》招銀國際降巨子生物目標價至73.54元 銷售復甦在望

2025-07-15T  
《大行》大摩:老鋪黃金及泡泡瑪特有潛在盈利上升空間 料海底撈、蒙牛盈利下行

2025-07-14T  
《大行》招銀國際建議理性看待創新藥估值

2025-07-09T  
《展望》券商港股首選股綜合名單(光大證券國際、中金)(表)

2025-06-30T  
《展望》騰訊、阿里、比亞迪及小米成券商下半年最受青睞股份

2025-06-30T  
巨子生物控股股東續增持 最新持股54.36%

2025-06-27T  
巨子生物控股股東增持逾92萬股 涉資4,670萬元

2025-06-26T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.